Mezzion Pharma Co.Ltd (140410) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.391x

Based on the latest financial reports, Mezzion Pharma Co.Ltd (140410) has a cash flow conversion efficiency ratio of -0.391x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.07 Billion ≈ $-4.11 Million USD) by net assets (₩15.51 Billion ≈ $10.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 140410 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Mezzion Pharma Co.Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Mezzion Pharma Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mezzion Pharma Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mezzion Pharma Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aurelia Metals Ltd AU:AMI	0.211x
Beijing Capital International Airport Company Limited F:BJ1	-0.022x
Paysafe Ltd NYSE:PSFE	0.114x
Pes Camanchaca SN:CAMANCHACA	0.052x
Xperi Corp NYSE:XPER	0.125x
Henan Rebecca Hair Products Co Ltd SHG:600439	0.032x
Thessaloniki Port Authority SA AT:OLTH	0.031x
Sumber Global Energy Tbk Pt JK:SGER	0.029x

Annual Cash Flow Conversion Efficiency for Mezzion Pharma Co.Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Mezzion Pharma Co.Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 140410 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩17.19 Billion ≈ $11.65 Million	₩-16.59 Billion ≈ $-11.24 Million	-0.965x	-140.34%
2024-12-31	₩46.06 Billion ≈ $31.22 Million	₩-18.49 Billion ≈ $-12.53 Million	-0.401x	-123.74%
2023-12-31	₩61.44 Billion ≈ $41.64 Million	₩-11.02 Billion ≈ $-7.47 Million	-0.179x	+61.01%
2022-12-31	₩26.24 Billion ≈ $17.78 Million	₩-12.07 Billion ≈ $-8.18 Million	-0.460x	-91.72%
2021-12-31	₩62.79 Billion ≈ $42.55 Million	₩-15.07 Billion ≈ $-10.21 Million	-0.240x	-84.84%
2020-12-31	₩56.81 Billion ≈ $38.50 Million	₩-7.38 Billion ≈ $-5.00 Million	-0.130x	+73.36%
2019-12-31	₩42.83 Billion ≈ $29.03 Million	₩-20.88 Billion ≈ $-14.15 Million	-0.488x	-28.63%
2018-12-31	₩57.32 Billion ≈ $38.84 Million	₩-21.72 Billion ≈ $-14.72 Million	-0.379x	-52.50%
2017-12-31	₩53.17 Billion ≈ $36.03 Million	₩-13.21 Billion ≈ $-8.95 Million	-0.249x	-115.96%
2016-12-31	₩52.81 Billion ≈ $35.79 Million	₩-6.08 Billion ≈ $-4.12 Million	-0.115x	-506.08%
2015-12-31	₩62.54 Billion ≈ $42.38 Million	₩1.77 Billion ≈ $1.20 Million	0.028x	-42.77%
2012-12-31	₩63.34 Billion ≈ $42.92 Million	₩3.14 Billion ≈ $2.13 Million	0.050x	--

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$371.25 Million

₩547.82 Billion KRW

Market Cap Rank

#13948 Global

#444 in Korea

Share Price

₩64100.00

Change (1 day)

+0.63%

52-Week Range

₩36450.00 - ₩172700.00

All Time High

₩172700.00